|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 31/506 | (2006.01) |
| A61K 31/337 | (2006.01) | ||
| A61K 31/357 | (2006.01) | ||
| A61K 31/4184 | (2006.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61K 31/4523 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| G01N 33/50 | (2006.01) |
| (11) | Patento numeris | 3902547 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19842712.2 |
| Europos patento paraiškos padavimo data | 2019-12-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-11-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-09-20 |
| (46) | Apibrėžties vertimo paskelbimo data | 2024-01-25 |
| (86) | Numeris | PCT/US2019/068311 |
| Data | 2019-12-23 |
| (87) | Numeris | WO 2020/139828 |
| Data | 2020-07-02 |
| (30) | Numeris | Data | Šalis |
| 201862786105 P | 2018-12-28 | US | |
| 201962926341 P | 2019-10-25 | US | |
| 201962933830 P | 2019-11-11 | US |
| (72) |
FLYNN, Daniel L. , US
SMITH, Bryan D. , US
SOTO, Rodrigo, Ruiz , US
KUIDA, Keisuke , US
|
| (73) |
Deciphera Pharmaceuticals, LLC ,
200 Smith Street, Waltham, MA 02451,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | CSF1R inhibitoriai, skirti panaudoti vėžio gydymui |
| CSF1R INHIBITORS FOR USE IN TREATING CANCER |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2024-12-03 | 6 | 139.00 EUR |
| 2025-12-23 |